who qualifies for glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The Science Behind GLP-1 Medications:

These effects translate experimentally to altered caloric intake and post-prandial glucose kinetics in rodent and non-human primate models

Semaglutide with the maximum dose of 2.4 mg (Wegovy) was not available in Austria at the time of enrollment

Tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, is substantially eliminated from the body within 23 weeks of discontinuation

But heres what NOBODY is telling you: The difference between these two stacks is far more than the addition or subtraction of one extra peptide

DailyMed - U.S

The spent variant arises after the molecule has performed its function